Shares of ProtoKinetix, Incorporated (OTCMKTS:PKTX – Get Free Report) crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.01 and traded as low as $0.0070. ProtoKinetix shares last traded at $0.0075, with a volume of 60,000 shares traded.
ProtoKinetix Stock Up 23.0%
The business’s fifty day simple moving average is $0.01 and its two-hundred day simple moving average is $0.01.
About ProtoKinetix
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions, including ophthalmology, dermatology, transplants, and biomanufacturing. It has a collaboration research agreement with the University of British Columbia. The company was formerly known as RJV Network, Inc and changed its name to ProtoKinetix, Incorporated in July 2003.
Featured Articles
- Five stocks we like better than ProtoKinetix
- The SK Hynix IPO and 2027’s AI Memory Squeeze
- Meta Platforms Stock Rises as Muse Spark 1.1 AI Model Debuts
- Why Welltower’s Growth Story Might Outrun Its Rich Valuation
- One Short- and One Long-Term ETF for Quantum Computing Bulls
Receive News & Ratings for ProtoKinetix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProtoKinetix and related companies with MarketBeat.com's FREE daily email newsletter.
